WallStreetZenWallStreetZen

NASDAQ: ASTH
Astrana Health Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for ASTH

Based on 8 analysts offering 12 month price targets for Astrana Health Inc

Min Forecast
$40.00+9.98%
Avg Forecast
$50.88+39.88%
Max Forecast
$65.00+78.72%

Should I buy or sell ASTH stock?

Based on 8 analysts offering ratings for Astrana Health Inc.

Strong Buy
Strong Buy
5 analysts 62.5%
Buy
3 analysts 37.5%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although ASTH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates ASTH as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their ASTH stock forecasts and price targets.

ASTH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-15
lockedlocked$00.00+00.00%2026-08-11
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-07-14
lockedlocked$00.00+00.00%2026-07-14Find Out Why
BTIG
Top 22%
79
Strong BuyReiterates$50.00+37.48%2026-06-02
Needham
Top 29%
72
BuyMaintains$41.00+12.73%2026-05-08
Baird
Bottom 6%
6
BuyMaintains$40.00+9.98%2026-04-15

1 of 1

Forecast return on equity

Is ASTH forecast to generate an efficient return?

Company
N/A
Industry
-86.05%
Market
168.26%

Forecast return on assets

Is ASTH forecast to generate an efficient return on assets?

Company
N/A
Industry
11.23%

ASTH earnings per share forecast

What is ASTH's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$1.42+70.9%
Avg 2 year Forecast
$2.01+142.31%
Avg 3 year Forecast
$2.72+227.39%
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

ASTH revenue forecast

What is ASTH's revenue in the next 3 years based on estimates from 12 analysts?

Avg 1 year Forecast
$4.1B+5.59%
Avg 2 year Forecast
$4.5B+16.46%
Avg 3 year Forecast
$4.9B+28.71%
ASTH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ASTH earnings growth forecast

How is ASTH forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
47.92%
Industry
5.43%
Market
31.78%
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
ASTH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

ASTH revenue growth forecast

How is ASTH forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
8.68%
Industry
3.54%
Market
13.9%
ASTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ASTH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ASTH vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
ASTH$36.37$50.88+39.88%Strong Buy
ADUS$113.19$124.25+9.77%Hold
MD$26.31$28.00+6.42%Hold
SGRY$14.40$17.75+23.26%Strong Buy
SNDA$37.71$49.50+31.26%Buy
View Top Medical Care Facility Stocks

Astrana Health Stock Forecast FAQ

Is Astrana Health Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: ASTH) stock is to Strong Buy ASTH stock.

Out of 8 analysts, 5 (62.5%) are recommending ASTH as a Strong Buy, 3 (37.5%) are recommending ASTH as a Buy, 0 (0%) are recommending ASTH as a Hold, 0 (0%) are recommending ASTH as a Sell, and 0 (0%) are recommending ASTH as a Strong Sell.

If you're new to stock investing, here's how to buy Astrana Health stock.

What is ASTH's earnings growth forecast for 2026-2028?

(NASDAQ: ASTH) Astrana Health's forecast annual earnings growth rate of 47.92% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 5.43%, and it is also forecast to beat the US market's average forecast earnings growth rate of 31.78%.

Astrana Health's earnings in 2026 is $40,547,000.On average, 13 Wall Street analysts forecast ASTH's earnings for 2026 to be $79,063,173, with the lowest ASTH earnings forecast at $61,723,340, and the highest ASTH earnings forecast at $94,223,683. On average, 13 Wall Street analysts forecast ASTH's earnings for 2027 to be $112,098,592, with the lowest ASTH earnings forecast at $78,110,067, and the highest ASTH earnings forecast at $145,139,585.

In 2028, ASTH is forecast to generate $151,454,607 in earnings, with the lowest earnings forecast at $115,253,316 and the highest earnings forecast at $178,498,281.

What is ASTH's revenue growth forecast for 2026-2028?

(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 8.68% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 3.54%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.

Astrana Health's revenue in 2026 is $3,844,194,000.On average, 12 Wall Street analysts forecast ASTH's revenue for 2026 to be $226,237,164,912, with the lowest ASTH revenue forecast at $216,093,000,336, and the highest ASTH revenue forecast at $236,102,643,648. On average, 12 Wall Street analysts forecast ASTH's revenue for 2027 to be $249,535,301,136, with the lowest ASTH revenue forecast at $231,532,195,872, and the highest ASTH revenue forecast at $268,653,149,760.

In 2028, ASTH is forecast to generate $275,787,507,264 in revenue, with the lowest revenue forecast at $257,728,664,832 and the highest revenue forecast at $302,151,187,728.

What is ASTH's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: ASTH) forecast ROA is N/A, which is lower than the forecast US Medical Care Facilities industry average of 11.23%.

What is ASTH's Price Target?

According to 8 Wall Street analysts that have issued a 1 year ASTH price target, the average ASTH price target is $50.88, with the highest ASTH stock price forecast at $65.00 and the lowest ASTH stock price forecast at $40.00.

On average, Wall Street analysts predict that Astrana Health's share price could reach $50.88 by Sep 15, 2027. The average Astrana Health stock price prediction forecasts a potential upside of 39.88% from the current ASTH share price of $36.37.

What is ASTH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: ASTH) Astrana Health's current Earnings Per Share (EPS) is $0.83. On average, analysts forecast that ASTH's EPS will be $1.42 for 2026, with the lowest EPS forecast at $1.11, and the highest EPS forecast at $1.69. On average, analysts forecast that ASTH's EPS will be $2.01 for 2027, with the lowest EPS forecast at $1.40, and the highest EPS forecast at $2.60. In 2028, ASTH's EPS is forecast to hit $2.72 (min: $2.07, max: $3.20).

What is ASTH's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: ASTH) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.